Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d’Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial

BACKGROUND: The 2016 World Health Organization guidelines recommend all children <3 years start antiretroviral therapy (ART) on protease inhibitor-based regimens. But lopinavir/ritonavir (LPV/r) syrup has many challenges in low-income countries, including limited availability, requires refrigerat...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahourou, Désiré Lucien, Amorissani-Folquet, Madeleine, Malateste, Karen, Amani-Bosse, Clarisse, Coulibaly, Malik, Seguin-Devaux, Carole, Toni, Thomas, Ouédraogo, Rasmata, Blanche, Stéphane, Yonaba, Caroline, Eboua, François, Lepage, Philippe, Avit, Divine, Ouédraogo, Sylvie, Van de Perre, Philippe, N’Gbeche, Sylvie, Kalmogho, Angèle, Salamon, Roger, Meda, Nicolas, Timité-Konan, Marguerite, Leroy, Valériane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402051/
https://www.ncbi.nlm.nih.gov/pubmed/28434406
http://dx.doi.org/10.1186/s12916-017-0842-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5402051/
https://www.ncbi.nlm.nih.gov/pubmed/28434406
http://dx.doi.org/10.1186/s12916-017-0842-4

Ejemplares similares